RankingsPricing
  1. JP-listed companies
  2. PhoenixBio Co.,Ltd.
  3. Financials
  4. Net income

PhoenixBio Co.,Ltd.JP:6190

Market cap
¥2B
P/E ratio
18x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 2025-449-1801.92%
Mar 31, 202426-94.65%
Mar 31, 2023493-227.16%
Mar 31, 2022-388+63.01%
Mar 31, 2021-238-42.75%
Mar 31, 2020-416+39.74%
Mar 31, 2019-297+9.86%
Mar 31, 2018-271-311.02%
Mar 31, 2017128+2.46%
Mar 31, 2016125+120.70%
Mar 31, 201557-60.58%
Mar 31, 2014144-330.51%
Mar 31, 2013-62-74.03%
Mar 31, 2012-240

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)